MYLAN ApS: Financial statements 2022
CVR: 28107013
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
MYLAN ApS (CVR 28107013) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,252 and a net result of DKK 50 compared with DKK 2,086 the year before. That is a decrease of 58.2% compared with the year before. Equity in the 2022 report amounted to DKK 193,889. The solvency ratio was 56.8%.
- Gross Profit
- DKK 2,252
- Profit/Loss
- DKK 50
- Equity
- DKK 193,889
- Total Assets
- DKK 341,101
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 2 t. | 50 | 194 t. | 0 |
| 2021 | - | 5 t. | 2 t. | 194 t. | 0 |
| 2020 | - | 5 t. | 2 t. | 192 t. | 0 |
| 2019 | - | 5 t. | 2 t. | 190 t. | 0 |
| 2018 | - | 3 t. | 1 t. | 188 t. | 0 |
Keep an eye on MYLAN ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
MYLAN ApS has published its annual report for 2021. Gross profit came to DKK 5,388, and the net result was DKK 2,086.
About MYLAN ApS
MYLAN ApS was a Danish company of the type Anpartsselskab based in Ballerup, founded in 2004. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERCK NM ApS and NM PHARMA ApS. In 2024, the company reported a gross profit of DKK 3,631 and a net result of DKK 3,137 compared with DKK 1,952 the year before. Equity in the 2024 report amounted to DKK 198,978.